University of Glasgow
Life after treatment for prostate cancer : Levels of anxiety, depression, and sexual dysfunction and research portfolio
Abstract
dc:description.abstractThis systematic review aimed to address the following questions: 'What is the prevalence of anxiety and depression in men with prostate cancer?' and 'Is there a relationship between anxiety, depression and sexual dysfunction in men with prostate cancer?' The purpose of the review was to investigate the quality of studies looking at levels of anxiety, depression and sexual dysfunction in a systematic way. An electronic search of suitable health databases was completed using five key terms to reflect the main components of the systematic review question. Twelve studies were then identified using inclusion and exclusion criteria and included in this review. The methodological quality of each of the twelve studies was examined using assessment criteria adapted from the Scottish Intercollegiate Guidelines Network (SIGN) 50 'A Guideline Developers' Handbook' [1]. Reported prevalence levels for 'clinically significant' anxiety ranged from 32.6% to 6.7%. Prevalence rates for 'clinically significant' depression ranged from 2% to 27%. Reported prevalence of sexual dysfunction ranged from 40 to 80%. Limitations of the current literature are discussed and suggestions for future research are proposed. Keywords - Prostate, cancer, anxiety, depression, sexual dysfunction.
Degree
thesis:*- Level dc:type.qualificationlevel
- DClinPsy
- Grantor dc:publisher.institution
- University of Glasgow
- Year dc:date.issued
- 2007
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Clifford, Rebecca
Rights
- Language dc:language
- en